Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 12

Results: 7

Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients: Ferric Carboxymaltose in Heart Failure: A. M. Taha et al.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 12, p. 879, doi. 10.1007/s40261-024-01401-y

By:

Taha, Amira Mohamed;
Elsaeidy, Ahmed Saad;
Nada, Sarah A.;
Sharma, Sadish;
Ghonaim, Mohamed M.;
Ahsan, Areeba;
Mourid, Marina Ramzy;
Abouelmagd, Khaled

Publication type:

Article

Acknowledgement to Referees: Acknowledgement to Referees: Acknowledgement to Referees.

Published in:: Clinical Drug Investigation, 2024, v. 44, n. 12, p. 875, doi. 10.1007/s40261-024-01412-9
Publication type:: Article

A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder: Evaluating New Injection Locations for Monthly Extended-Release Buprenorphine: C. M. Laffont et al

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 12, p. 939, doi. 10.1007/s40261-024-01406-7

By:

Laffont, Celine M.;
Lapeyra, Olga;
Mangal, Dipti;
Dobbins, Robert

Publication type:

Article

A Network Meta-Analysis of Vasodilator Therapies in Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: Insights for Optimizing Hemodynamics: Vasodilator Therapy for PH in Patients Undergoing Mitral Valve Replacement Surgery: A. Elrosasy et al

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 12, p. 897, doi. 10.1007/s40261-024-01404-9

By:

Elrosasy, Amr;
Maher, Ahmed;
Ramadan, Abdelraouf;
Hamam, Nada G.;
Soliman, Mohamed;
Kamal, Sara K.;
Milik, Beshoy Emad;
Shahat, Abdullah Ali;
Kamel, Menna Nabil;
Ali, Ahmed Abdeltawab;
Hassan, Loay Abdelnabi;
Zabady, Ahmed;
Zeid, Mohamed Abo;
Abdelmottaleb, Wael;
Nassar, Sameh

Publication type:

Article

Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz®) in Europe: A Prescriber Survey: Evaluation of Tofacitinib aRMM: J. Wu et al.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 12, p. 961, doi. 10.1007/s40261-024-01408-5

By:

Wu, Joanne;
Koram, Nana;
Asomaning, Kofi;
Merchant, Lubna;
Massouh, Robert;
Nagy, Edward;
Khalid, Subhan;
Walsh, Laura;
Bosan, Rafia;
Cantos, Krystal

Publication type:

Article

A Phase I Clinical Trial to Evaluate the Bioequivalence of an Adalimumab Biosimilar Adalimumab-WIBP and Humira®: Bioequivalence Trial of Adalimumab-WIBP and Humira®: S. Hu et al.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 12, p. 951, doi. 10.1007/s40261-024-01409-4

By:

Hu, Shengling;
Liu, Yang;
Yang, Lu;
Yang, Yunkai;
Long, Feiguang;
Bao, Hongying;
Zhang, Huijun;
Yue, Xin;
Zhang, Jiayou;
Wang, Zejun;
Huang, Chaolin;
Wang, Jingli;
Xia, Liu;
Pan, Yongbing;
Zhang, Yuntao;
Gong, Fengyun

Publication type:

Article

Cost-Effectiveness Analysis of Adjuvant Pertuzumab and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer in Japan: CEA of Adjuvant Pertuzumab and Trastuzumab in HER2+ eBC in Japan: C. Nusawat et al.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 12, p. 927, doi. 10.1007/s40261-024-01399-3

By:

Nusawat, Chanon;
Sato, So;
Watanabe, Hideaki;
Konishi, Takaaki;
Yamana, Hayato;
Yasunaga, Hideo

Publication type:

Article

Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 12

Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients: Ferric Carboxymaltose in Heart Failure: A. M. Taha et al.

Acknowledgement to Referees: Acknowledgement to Referees: Acknowledgement to Referees.

A Network Meta-Analysis of Vasodilator Therapies in Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: Insights for Optimizing Hemodynamics: Vasodilator Therapy for PH in Patients Undergoing Mitral Valve Replacement Surgery: A. Elrosasy et al

Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz<sup>®</sup>) in Europe: A Prescriber Survey: Evaluation of Tofacitinib aRMM: J. Wu et al.

A Phase I Clinical Trial to Evaluate the Bioequivalence of an Adalimumab Biosimilar Adalimumab-WIBP and Humira<sup>®</sup>: Bioequivalence Trial of Adalimumab-WIBP and Humira<sup>®</sup>: S. Hu et al.

Cost-Effectiveness Analysis of Adjuvant Pertuzumab and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer in Japan: CEA of Adjuvant Pertuzumab and Trastuzumab in HER2+ eBC in Japan: C. Nusawat et al.